126 related articles for article (PubMed ID: 36993550)
1. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
bioRxiv; 2023 Mar; ():. PubMed ID: 36993550
[TBL] [Abstract][Full Text] [Related]
2. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Güllülü Ö; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
J Biol Chem; 2023 Dec; 299(12):105427. PubMed ID: 37926283
[TBL] [Abstract][Full Text] [Related]
3. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
[TBL] [Abstract][Full Text] [Related]
4. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
Cuneo MJ; O'Flynn BG; Lo YH; Sabri N; Mittag T
Mol Cell; 2023 Mar; 83(5):731-745.e4. PubMed ID: 36693379
[TBL] [Abstract][Full Text] [Related]
5. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
[TBL] [Abstract][Full Text] [Related]
7. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase adaptor SPOP in cancer.
Cuneo MJ; Mittag T
FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
[TBL] [Abstract][Full Text] [Related]
9. Protein Network Structure Enables Switching between Liquid and Gel States.
Schmit JD; Bouchard JJ; Martin EW; Mittag T
J Am Chem Soc; 2020 Jan; 142(2):874-883. PubMed ID: 31845799
[TBL] [Abstract][Full Text] [Related]
10. Conformational and oligomeric states of SPOP from small-angle X-ray scattering and molecular dynamics simulations.
Thomasen FE; Cuneo MJ; Mittag T; Lindorff-Larsen K
Elife; 2023 Mar; 12():. PubMed ID: 36856266
[TBL] [Abstract][Full Text] [Related]
11. Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination.
Pierce WK; Grace CR; Lee J; Nourse A; Marzahn MR; Watson ER; High AA; Peng J; Schulman BA; Mittag T
J Mol Biol; 2016 Mar; 428(6):1256-1271. PubMed ID: 26475525
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
van Geersdaele LK; Stead MA; Harrison CM; Carr SB; Close HJ; Rosbrook GO; Connell SD; Wright SC
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1677-84. PubMed ID: 23999291
[TBL] [Abstract][Full Text] [Related]
14. Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity.
Usher ET; Sabri N; Rohac R; Boal AK; Mittag T; Showalter SA
J Biol Chem; 2021; 296():100693. PubMed ID: 33894201
[TBL] [Abstract][Full Text] [Related]
15. Enhanced autophagy and NFE2L2/NRF2 pathway activation in SPOP mutation-driven prostate cancer.
Gao K; Shi Q; Liu Y; Wang C
Autophagy; 2022 Aug; 18(8):2013-2015. PubMed ID: 35438056
[TBL] [Abstract][Full Text] [Related]
16. The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
Sakaue T; Sakakibara I; Uesugi T; Fujisaki A; Nakashiro KI; Hamakawa H; Kubota E; Joh T; Imai Y; Izutani H; Higashiyama S
Sci Rep; 2017 Feb; 7():42845. PubMed ID: 28216678
[TBL] [Abstract][Full Text] [Related]
17. SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF.
Feng K; Shi Q; Jiao D; Chen Y; Yang W; Su K; Wang Y; Huang Y; Zhang P; Li Y; Wang C
Cell Biosci; 2022 Dec; 12(1):211. PubMed ID: 36585710
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP).
Zhou C; Hao X; Chen Z; Zhang R; Zhou Q; Fan Z; Zheng M; Hou H; Zhang S; Guo H
ACS Med Chem Lett; 2024 Feb; 15(2):270-279. PubMed ID: 38352842
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.
Gao K; Jin X; Tang Y; Ma J; Peng J; Yu L; Zhang P; Wang C
Am J Cancer Res; 2015; 5(10):3210-20. PubMed ID: 26693071
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
